APA (7th ed.) Citation

Hanaa Badran, Maha Elsabaawy, Mahmoud Magdy, Samar Ghanem, Mohammed Said, Mohamed Hamdy Torky, & Tamer Samir. (2024). The utility of pentraxin 3 and platelet-derived growth factor receptor beta as non-invasive biomarkers for prediction of cardiovascular risk in MAFLD patients. SpringerOpen.

Chicago Style (17th ed.) Citation

Hanaa Badran, Maha Elsabaawy, Mahmoud Magdy, Samar Ghanem, Mohammed Said, Mohamed Hamdy Torky, and Tamer Samir. The Utility of Pentraxin 3 and Platelet-derived Growth Factor Receptor Beta as Non-invasive Biomarkers for Prediction of Cardiovascular Risk in MAFLD Patients. SpringerOpen, 2024.

MLA (9th ed.) Citation

Hanaa Badran, et al. The Utility of Pentraxin 3 and Platelet-derived Growth Factor Receptor Beta as Non-invasive Biomarkers for Prediction of Cardiovascular Risk in MAFLD Patients. SpringerOpen, 2024.